What happened to SF Pharmaceutical?

On February 10, China Resources Sanjiu announced that the company had signed the Equity Transfer Contract with the shareholders of SF Pharmaceutical, and the company acquired 0/00% equity of SF Pharmaceutical/KLOC-0 at a price of 600 million yuan. This means that less than two months after China Resources Sanjiu took over SF Pharmaceutical, it was really surprising that it encountered environmental problems. It can be seen that it is acquired.